Perle Bioscience, Inc. — Form D
Perle Bioscience, Inc. of CHARLESTON, SC, a company, filed a Form D exempt-offering notice with the SEC on 2015-12-07. The offering totals $2.8M, of which $1.7M was reported sold. Industry: Other.
Offering
- Filed: 2015-12-07
- Form: D
- Accession: 0001605829-15-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $2.8M
- Amount sold: $1.7M
- Remaining: $1.0M
- Investors: 2
- Date of first sale: 2015-11-24
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-252501
Issuer
- Name: Perle Bioscience, Inc.
- CIK: 0001605829
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 520 FOLLY ROAD, SUITE P212, CHARLESTON, SC, 29412
- Phone: 843-568-2603
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Ryan N Fiorini | Director | Charleston, SC |
| Ryan N Fiorini | Executive Officer | Charleston, SC |
| Jeffrey N Riley | Director | Charleston, SC |
| Lloyd A Pearson | Executive Officer | Greenville, NC |
| Douglas N Carnes | Director | Charleston, SC |
| Donna N Hill | Director | Charleston, SC |
| Claresa N Levetan | Director | Charleston, SC |
| Claresa N Levetan | Executive Officer | Charleston, SC |
| Gilbert N Nathan | Director | Charleston, SC |
Other filings by this issuer (4)
More